Sonio

📍 Paris, France🗓 Founded 2020👥 97 employees💰 Last funded Mar 2023
Software Development🌐 sonio.ai
Website LinkedIn
Sonio, a wholly-owned subsidiary of Samsung Medison Co., Ltd since 2024, is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. "Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI. ¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product * Applicable to V1 only, Data enclosed at Sonio **See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf
5
Total investors
4
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
4
Belgium
1
Investor activity2022–2023 · investors recorded per year
2022420231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sonio?
Sonio has 5 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage.
When did Sonio last raise funding?
The most recent investment in Sonio recorded on gritt.io was in March 2023.
When was Sonio founded?
Sonio was founded in 2020.
What industry is Sonio in?
Sonio operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Sonio based?
Sonio is headquartered in Paris, France.